View Older Stories View More Recent Stories
-
Form SC 13D Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
-
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
-
Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders
-
Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A IO Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A EyePoint Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Pyxis Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A BELLUS Health Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Form SC 13G/A Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A IMARA Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Entera Bio Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Cogent Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G HilleVax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Instil Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ImmunoGen, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ALPINE IMMUNE SCIENCES, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A BCLS Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A PhaseBio Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A PARDES BIOSCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CONCERT PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A SYNLOGIC, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A 5:01 Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Vera Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Orchestra BioMed Holding Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Magenta Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
T-knife Therapeutics Announces the Appointment of Behzad Kharabi, M.D., as Chief Medical Officer
-
T-knife Therapeutics Announces the Appointment of Behzad Kharabi, M.D., as Chief Medical Officer
-
Apogee Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer
-
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
-
Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria
